BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33170303)

  • 1. Protein and mRNA Expression Levels of Interleukin-17A, -17F and -22 in Blood and Skin Samples of Patients with Mycosis Fungoides.
    Papathemeli D; Patsatsi A; Papanastassiou D; Koletsa T; Papathemelis T; Avgeros C; Pikou O; Lazaridou E; Georgiou E
    Acta Derm Venereol; 2020 Nov; 100(18):adv00326. PubMed ID: 33170303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).
    Willerslev-Olsen A; Litvinov IV; Fredholm SM; Petersen DL; Sibbesen NA; Gniadecki R; Zhang Q; Bonefeld CM; Wasik MA; Geisler C; Zhou Y; Woetmann A; Sasseville D; Krejsgaard T; Odum N
    Cell Cycle; 2014; 13(8):1306-12. PubMed ID: 24621498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.
    Krejsgaard T; Litvinov IV; Wang Y; Xia L; Willerslev-Olsen A; Koralov SB; Kopp KL; Bonefeld CM; Wasik MA; Geisler C; Woetmann A; Zhou Y; Sasseville D; Odum N
    Blood; 2013 Aug; 122(6):943-50. PubMed ID: 23801634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides.
    Chong BF; Wilson AJ; Gibson HM; Hafner MS; Luo Y; Hedgcock CJ; Wong HK
    Clin Cancer Res; 2008 Feb; 14(3):646-53. PubMed ID: 18245523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.
    Ohmatsu H; Humme D; Gulati N; Gonzalez J; Möbs M; Suárez-Fariñas M; Cardinale I; Mitsui H; Guttman-Yassky E; Sterry W; Krueger JG
    Cancer Immunol Res; 2014 Sep; 2(9):890-900. PubMed ID: 24938282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome.
    Möbs M; Gryzik S; Haidar A; Humme D; Beyer M; Vandersee S
    Arch Dermatol Res; 2015 Aug; 307(6):479-85. PubMed ID: 25488078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17 Genes Polymorphisms are Significantly Associated with Cutaneous T-cell Lymphoma Susceptibility.
    Kołkowski K; Jolanta Gleń ; Berenika Olszewska ; Monika Zabłotna ; Nowicki RJ; Małgorzata Sokołowska-Wojdyło
    Acta Derm Venereol; 2022 Sep; 102():adv00777. PubMed ID: 35971833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased interleukin-21 expression in skin and blood in advanced mycosis fungoides.
    Kabasawa M; Sugaya M; Oka T; Takahashi N; Kawaguchi M; Suga H; Miyagaki T; Takahashi T; Shibata S; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
    J Dermatol; 2016 Jul; 43(7):819-22. PubMed ID: 26825047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
    Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
    J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of B-cells in Mycosis Fungoides.
    Nielsen PR; Eriksen JO; Sørensen MD; Wehkamp U; Lindahl LM; Bzorek M; Iversen L; Woetman A; Ødum N; Litman T; Gjerdrum LMR
    Acta Derm Venereol; 2021 Mar; 101(3):adv00413. PubMed ID: 33686443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Leroy S; Dubois S; Tenaud I; Chebassier N; Godard A; Jacques Y; Dréno B
    Br J Dermatol; 2001 May; 144(5):1016-23. PubMed ID: 11359391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-7 mRNA is not overexpressed in mycosis fungoides and pleomorphic T-cell lymphoma and is likely to be an autocrine growth factor in vivo.
    Asadullah K; Haeussler A; Friedrich M; Siegling A; Olaizola-Horn S; Trefzer U; Volk HD; Sterry W
    Arch Dermatol Res; 1996 Dec; 289(1):9-13. PubMed ID: 9017129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides.
    Blaschke V; Reich K; Middel P; Letschert M; Sachse F; Harwix S; Neumann C
    J Invest Dermatol; 1999 Oct; 113(4):658-63. PubMed ID: 10504456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
    Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
    Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine profile of patients with mycosis fungoides and the immunomodulatory effect of AS101.
    Shohat M; Hodak E; Sredni B; Shohat B; Sredni D; David M
    Acta Derm Venereol; 2001; 81(4):255-7. PubMed ID: 11720171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activity of IL-17 in cutaneous T-cell lymphomas (mycosis fungoides and Sezary syndrome).
    Cirée A; Michel L; Camilleri-Bröet S; Jean Louis F; Oster M; Flageul B; Senet P; Fossiez F; Fridman WH; Bachelez H; Tartour E
    Int J Cancer; 2004 Oct; 112(1):113-20. PubMed ID: 15305382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression and Potential Regulatory Role of IL-17F in Pathogenesis of Chronic Periodontitis.
    Luo Z; Wang H; Chen J; Kang J; Sun Z; Wu Y
    Inflammation; 2015; 38(3):978-86. PubMed ID: 25384562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.